Keyphrases
Dutch
100%
Adult Survivors of childhood Cancer
100%
Childhood Cancer Survivor Study
100%
Metabolic Syndrome
100%
Metabolic Syndrome Parameters
100%
Risk Factors
30%
Childhood Cancer Survivors
30%
Survivors
30%
Diagnostic Value
30%
Predictive Value
20%
Cardiovascular and Cerebrovascular Diseases
20%
Childhood Cancer
10%
Pediatric Oncology
10%
Netherlands
10%
Long-term Survivors
10%
Surveillance Guidelines
10%
National Cohort Study
10%
Genetic Predisposition
10%
Risk Stratification
10%
Genetic Variation
10%
Quality of Life
10%
Body Composition
10%
Single nucleotide Polymorphism Analysis
10%
Adult Treatment
10%
Dual-energy X-ray Absorptiometry
10%
Prevalence Factors
10%
National Cohort
10%
Oncology Hospital
10%
Patient Characteristics
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Hypertension
10%
Genetic Determinants
10%
Novel Biomarkers
10%
Biomarker Testing
10%
Previous Treatment
10%
Insulin Resistance
10%
Late Effects of Cancer Treatment
10%
Adiposity
10%
Timely Diagnosis
10%
Clinical Determinants
10%
Preventive Strategies
10%
Screening Strategy
10%
Cardiovascular Complications
10%
Diagnosis Strategy
10%
Separate Components
10%
Cerebrovascular Accident
10%
Dyslipidemia
10%
Patient Accrual
10%
Risk Screening
10%
Stratification Strategy
10%
Treatment Variation
10%
Panel Report
10%
National Cholesterol Education Program
10%
Background Potential
10%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Genetics
50%
Genetic Divergence
50%
Genetic Predisposition
50%
Single-Nucleotide Polymorphism
50%
Cohort Study
50%
Genetic Variation
50%
Insulin Resistance
50%
Body Composition
50%
Cross Sectional Study
50%
Dyslipidemia
50%
Medicine and Dentistry
Childhood Cancer
100%
Biological Marker
100%
Metabolic Syndrome
100%
Diagnosis
27%
Prevalence
18%
Genetic Predisposition
9%
Cohort Analysis
9%
Risk Stratification
9%
Single Nucleotide Polymorphism
9%
Genetic Variation
9%
Quality of Life
9%
Cardiovascular Disease
9%
Patient Characteristics
9%
Cross Sectional Study
9%
Diabetes Mellitus
9%
Insulin Resistance
9%
Cardiovascular System
9%
Obesity
9%
Absorptiometry
9%
Late Effect of Treatment
9%
Dyslipidemia
9%
Cerebrovascular Disease
9%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Childhood Cancer
100%
Metabolic Syndrome X
100%
Prevalence
18%
Cohort Study
9%
Genetic Predisposition
9%
Diabetes Mellitus
9%
Obesity
9%
Cross-Sectional Study
9%
Insulin Resistance
9%
Dyslipidemia
9%
Cerebrovascular Disease
9%
Cardiovascular Disease
9%